---
title: "Vicarious Surgical Announces Upcoming Chief Financial Officer Resignation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290745157.md"
description: "Vicarious Surgical (RBOT) announced that CFO Sarah Romano will resign effective July 22, 2026. The company stated the departure is amicable and not due to disputes, with Romano staying until her exit to ensure leadership continuity. This change occurs as the medical robotics firm advances technology commercialization. Analysts currently rate RBOT a Hold with a $7.00 target, while TipRanks' AI suggests Underperform due to weak financials and bearish technicals."
datetime: "2026-06-24T21:50:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290745157.md)
  - [en](https://longbridge.com/en/news/290745157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290745157.md)
---

# Vicarious Surgical Announces Upcoming Chief Financial Officer Resignation

The latest announcement is out from Vicarious Surgical ( (RBOT) ).

On June 24, 2026, Vicarious Surgical disclosed that Chief Financial Officer Sarah Romano has submitted her resignation, with her departure slated to take effect on July 22, 2026, or a later mutually agreed date. The company emphasized that Romano’s decision was not driven by any dispute over operations, policies, or practices, and she will remain in her role as CFO until her resignation becomes effective, helping to support continuity in financial leadership during the transition.

Her planned exit signals an upcoming change in the finance leadership team at a critical period for the medical robotics firm, which relies on stable financial stewardship as it advances the commercialization of its technology. While the announcement did not detail succession plans, the company’s clarification that there were no disagreements tied to the move aims to reassure investors and other stakeholders about the stability of its governance and strategic direction.

The most recent analyst rating on (RBOT) stock is a Hold  
with a $7.00 price target.  
To see the full list of analyst forecasts on Vicarious Surgical stock,  
see the RBOT Stock Forecast page.

**Spark’s Take on RBOT Stock**

According to Spark, TipRanks’ AI Analyst, RBOT is a Underperform.

The score is held down primarily by weak financial performance (zero revenue, large ongoing losses/cash burn, and a much smaller equity cushion that increases funding risk) and very bearish technicals (price far below all major moving averages with negative momentum). Valuation provides little support given a negative P/E and no dividend yield data.

To see Spark’s full report on RBOT stock,  
click here.

**More about Vicarious Surgical**

Vicarious Surgical operates in the medical technology industry, focusing on the development of advanced surgical robotics systems intended to enhance minimally invasive procedures. The company targets hospitals and healthcare providers seeking to improve surgical precision, reduce patient recovery times, and modernize operating room capabilities with next-generation robotic platforms.

**Average Trading Volume:** 46,486

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $1.43M

### Related Stocks

- [RBOT.US](https://longbridge.com/en/quote/RBOT.US.md)
- [RBOTW.US](https://longbridge.com/en/quote/RBOTW.US.md)
- [RBOT+.US](https://longbridge.com/en/quote/RBOT+.US.md)

## Related News & Research

- [China's Lumos eyes fresh funding, potential listing as factory robot sales grow](https://longbridge.com/en/news/296187333.md)
- [AIxCrypto plans exit from digital asset treasury strategy, shifts focus to robotics operations commercialization](https://longbridge.com/en/news/296236070.md)
- [Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlook](https://longbridge.com/en/news/295928913.md)
- [Serve Robotics partners with Grubhub in robot delivery expansion push](https://longbridge.com/en/news/296101655.md)
- [Monarch Alternative Capital sells eight seniors housing properties in portfolio exit](https://longbridge.com/en/news/296240718.md)